KenCord Bio Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business
  • Financing Rounds
  • 2

KenCord Bio Therapeutics General Information

Description

Operator of an integrated pharmaceutical company intended to develop the specialty pharmaceutical business into a borderless marketplace. The company's focus lies in the rapid expansion of its sales, marketing and distribution capabilities of the brand, generic and OTC products, through building its own internal product pipeline through acquisition and licensing of both late-stage development products and technologies for domestic and international distribution.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Charlotte, NC
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KenCord Bio Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KenCord Bio Therapeutics‘s full profile, request access.

Request a free trial

KenCord Bio Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Ken Wiggins Founder, Chief Executive Officer & Chief Operating Officer
To view KenCord Bio Therapeutics’s complete executive team members history, request access »